Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized Controlled Clinical Trial to Evaluate the Safety and Effectiveness of the Resonova® CHORDS® Cerebral Protection System in Capturing and Removing Embolic Debris During Transcatheter Aortic Valve Replacement

NCT07648693 is registered in ClinicalTrials.gov with Resonova (Shanghai) Medtech Limited as lead sponsor.

NCT NCT07648693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07648693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized Controlled Clinical Trial to Evaluate the Safety and Effectiveness of the Resonova® CHORDS® Cerebral Protection System in Capturing and Removing Embolic Debris During Transcatheter Aortic Valve Replacement
Lead sponsor
Resonova (Shanghai) Medtech Limited
Phase
Not applicable
Overall status
Recruiting
Start date
October 31, 2025
Completion date
December 31, 2026
Enrollment
240 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral vascular accident (cva)/stroke, transcatheter aortic valve replacement (tavr)